期刊文献+

替卡格雷中间体4,6-二氯-5-氨基-2-丙硫基嘧啶的合成 被引量:1

Synthesis of Ticagrelor Intermediate
下载PDF
导出
摘要 以氨基丙二酸二乙酯、硫脲、碘丙烷等为原料,经保护、环合、烷基化反应合成标题化合物。标题化合物经1HNMR、13CNMR确证化学结构,总产率达51.4%。为标题化合物的工业化生产提供了一条较为合理的工艺路线,也为替卡格雷生产提供合格的原料。 To synthesize intermediate of clopidogrel 4,6-di- choloro-5-amino-2-propyhhiopyrimidine. 4, 6-Dicholoro-5-a- mino-2-propyhhiopyrimidine was synthesized using amino malonie acid diethylester,thiourea and iodopropane as materials by protective reaction, nucleophilic substitution reaction and etc. The structure of the target compound was confirmed by 1HNMR,13 CNMR and etc. The overall yield of title compound was 51.4%. This work provided a more reasonable route for the production process of 4,6-dicholoro-5-amino-2-propyhhio- pyrimidinc.
出处 《化学试剂》 CAS CSCD 北大核心 2014年第7期667-669,共3页 Chemical Reagents
关键词 4 6-二氯-5-氨基-2-丙硫基嘧啶 替卡格雷 中间体 合成 4, 6-dicholoro-5-amino-2-propylthiopyrimidine ticagre]or intermediate synthesis
  • 相关文献

参考文献11

  • 1陈莉莉,岑均达.替卡格雷合成路线图解[J].中国医药工业杂志,2011,42(2):146-150. 被引量:13
  • 2徐颂,于鹏,赵丽嘉,刘永贵,陈常青.盐酸替卡格雷[J].现代药物与临床,2010,25(1):64-66. 被引量:3
  • 3杨臻峥,晋展.抗凝血药替卡格雷[J].药学进展,2008,32(9):425-427. 被引量:5
  • 4LARSSON U, MAGNUSSON M, MUSIL T. Novel triazol- opyrimidine compounds: US,2 003 148 888 [ P]. 2003- 08-07. 被引量:1
  • 5LARRON U, MAGNUSSON M,MUSIL T,ct al. Novel tri- azolo pyrimidine compounds : U S, 20 070 049 755 A 1 [ P 1. 2007-03-01. 被引量:1
  • 6LARSSON U ,MATTIAS M ,TIBOR M ,et al. Novel triazo- lopyrimidine compounds : WO, 0 192 263A1 [ P ]. 2001- 12-06. 被引量:1
  • 7NAIR V,TRIVEDI N, KHILE AS, et al. Novel process for preparing triazolo[ 4,5-d] pyrimidine derivatives and in- termediates thereof: WO, 2 012 085 665 [ P ]. 2003-06- 28. 被引量:1
  • 8CREPALDI P, CACCIARI B. 6-Amino-2-mercapto-3H- pyrimidin-4-one derivatives as new candidates for the an- tagonism at the P2Y12 receptors [ J ]. Bioorg. Med. Chem. ,2009,17(13) :4 612-4 621. 被引量:1
  • 9CREPALDI P, CACCIARI B. 6-Amino-2-mercapto-3H- pyrimidin-4-one derivatives as new candidates for the an- tagonism at the P2Y12 receptors [ J ]. Bioorg. Med. Chem. ,2009,17(13) :4 612-4 621. 被引量:1
  • 10RAO T, ZHANG Cheng-zhi. Cyclopropyl modulators of P2Y12 receptor:WO,2 011 017 108 [ P]. 2011-02-10. 被引量:1

二级参考文献29

  • 1Owen R T, Serradell N, Bolos J. AZD6140: antiplatelet therapy P2Y12(P2T) receptor antagonist [J]. Drug Fut, 2007, 32(10): 845-853. 被引量:1
  • 2Springthorpe B, Bailey A, Barton P, et al. From ATP to AZD6140: The diseovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis[J]. Bioorg Med Chem Lett, 2007, 17(21): 6013-6018. 被引量:1
  • 3Kowalczyk M, Banaeh M, Mikhailidis D P, et al. Tieagrelora new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors? [J]. Med Sei Monit, 2009, 15(12): MS24-MS30. 被引量:1
  • 4Larsson U, Magnusson M, Musil T, et al. Novel triazole pyrimidine compounds: US, 2003148888A1 [P]. 2003-08-07. 被引量:1
  • 5Storey R F. New developments in antiplatelet therapy [J]. Eur Heart J, 2008, 10(Suppl D): 30-37. 被引量:1
  • 6Michelson A D. New P2Y12 antagonists [J]. Curr Opin Hematol, 2009, 16(5): 371-377. 被引量:1
  • 7Cattaneo M. New P2Y12 blockers [J]. J Thromb Haemost, 2009, 7(Suppl 1): 262-265. 被引量:1
  • 8Wallentin L, Becker R C, Budaj A, et al. Tieagrelor versus clopidogrel in patients with acute coronary syndromes[J]. N Engl J Med, 2009, 361(11): 1045-1057. 被引量:1
  • 9Owen RT,Serradell N,Bolos J.AZD6140[J].Drugs Future,2007,32 (10):845-853. 被引量:1
  • 10Hardern D,Ingall A,Springthorpe B,et al.Triazolo (4,5-d)pyrimidine compounds:US,6525060[P].2003-02-25. 被引量:1

共引文献17

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部